Met Life Investment Management, LLC Infinity Pharmaceuticals, Inc. Transaction History

Met Life Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$1.86 - $3.36 $61,608 - $111,293	-33,123 Closed	0 $0
Q3 2021 May 17, 2024	BUY	$1.52 - $3.82 $50,346 - $126,529	33,123 New	33,123 $113,000
Q3 2021 Jun 21, 2023	BUY	$1.52 - $3.82 $50,346 - $126,529	33,123 New	33,123 $113,000
Q3 2021 Mar 22, 2023	BUY	$1.52 - $3.82 $50,346 - $126,529	33,123 New	33,123 $113,000
Q3 2021 Nov 15, 2021	BUY	$1.52 - $3.82 $50,346 - $126,529	33,123 New	33,123 $113,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Met Life Investment Management, LLC with notifications on news.